Transcripts

TScan Therapeutics (TCRX) earnings call transcripts

Earnings call transcripts for TScan Therapeutics, Inc., with a summary, the guidance given, and what analysts pressed on.

  • business update, September 1, 2026

    Management repositioned TScan around two in-vivo solid-tumor candidates while pausing underfunded heme development and seeking partnerships.

    Sep 02, 2026Mildly positive0.35